Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. World Gastroenterology Organisation. Irritable bowel syndrome: a global perspective. 2009. http://www.worldgastroenterology.org . Accessed 17 June 2015.
2. Ford AC, Moayyedi P, Lacy BE, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109(Suppl. 1):S2–26.
3. NIHR Horizon Scanning Centre. Eluxadoline for irritable bowel syndrome (diarrhoea-predominant)—first line: NIHR Horizon Scanning Centre, University of Birmingham, 2014. Contract No.: 6758.
4. Barboza JL, Talley NJ, Moshiree B. Current and emerging pharmacotherapeutic options for irritable bowel syndrome. Drugs. 2014;74(16):1849–70.
5. Actavis. Viberzi™ (eluxadoline tablets): US prescribing information. 2015. http://www.actavis.com . Accessed 15 June 2015.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献